Functional imaging in pre-motor Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Quarterly Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2014-11-04

• Fields of study

  Medicine

• Identifiers
  PMID 25366709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prodromal features for Parkinson's disease – baseline data from the TREND study

  2014cited by this paper
• Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders

  2014cited by this paper
• MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.

  2014cited by this paper
• Low clinical diagnostic accuracy of early vs advanced Parkinson disease

  2014cited by this paper
• Abnormal metabolic network activity in REM sleep behavior disorder

  2014cited by this paper
• Primary visual cortical metabolism and rapid eye movement sleep behavior disorder in dementia with Lewy bodies

  2014cited by this paper
• Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study

  2013cited by this paper
• Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

  2013cited by this paper
• Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease

  2013cited by this paper
• Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients.

  2013cited by this paper
• Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder.

  2013cited by this paper
• Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?

  2013cited by this paper
• New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease

  2013cited by this paper
• Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.

  2013cited by this paper
• α-synuclein Imaging: A Critical Need for Parkinson's Disease Research

  2013cited by this paper
• Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

  2013cited by this paper
• Is rapid eye movement sleep behavior disorder in Parkinson disease a specific disease subtype?

  2013cited by this paper
• Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.

  2013cited by this paper
• Different diagnostic criteria for Parkinson disease: what are the pitfalls?

  2013cited by this paper
• Toward a redefinition of Parkinson's disease

  2012cited by this paper
• Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease

  2012cited by this paper
• Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome study

  2012cited by this paper
• Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based study

  2012cited by this paper
• New molecular targets for PET and SPECT imaging in neurodegenerative diseases.

  2012cited by this paper
• Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease

  2012cited by this paper
• Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.

  2012cited by this paper
• REM sleep behavior disorder: Motor manifestations and pathophysiology

  2012cited by this paper
• Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis

  2012cited by this paper
• Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment: a TMS study.

  2012cited by this paper
• Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment

  2012cited by this paper
• Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease

  2012cited by this paper
• Serotonin control of sleep-wake behavior.

  2011cited by this paper
• Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder.

  2011cited by this paper
• Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson’s disease

  2011cited by this paper
• Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder

  2011cited by this paper
• Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease

  2011cited by this paper
• Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

  2011cited by this paper
• Gastrointestinal dysfunction in Parkinson's disease.

  2011cited by this paper
• Classification of movement disorders

  2011cited by this paper
• Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder

  2011cited by this paper
• Diffuse occipital hypometabolism on [18F]‐FDG PET scans in patients with idiopathic REM sleep behavior disorder: Prodromal dementia with Lewy bodies?

  2010cited by this paper
• Best practice guide for the treatment of REM sleep behavior disorder (RBD).

  2010cited by this paper
• In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy.

  2010cited by this paper
• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

  2010cited by this paper
• The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder

  2010cited by this paper
• REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream?

  2010cited by this paper
• Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease.

  2010cited by this paper
• Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease.

  2010cited by this paper
• Clinical prediction of Parkinson's disease: planning for the age of neuroprotection

  2010cited by this paper
• Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.

  2010cited by this paper
• Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study

  2010cited by this paper
• Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

  2010cited by this paper
• Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease

  2010cited by this paper
• Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

  2009cited by this paper
• Parkinson’s Disease with and without REM Sleep Behaviour Disorder: Are There Any Clinical Differences?

  2009cited by this paper
• In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.

  2009cited by this paper
• Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

  2009cited by this paper
• Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

  2009cited by this paper
• Serotonin and Parkinson's disease: On movement, mood, and madness

  2009cited by this paper
• Sleep disorders and daytime sleepiness in Parkinson’s disease

  2009cited by this paper
• Medical records documentation of constipation preceding Parkinson disease

  2009cited by this paper
• Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

  2009cited by this paper
• Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

  2009cited by this paper
• Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

  2009cited by this paper
• 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.

  2008cited by this paper
• A systematic review of prevalence studies of depression in Parkinson's disease

  2008cited by this paper
• Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease?

  2008cited by this paper
• Assessment of idiopathic rapid‐eye‐movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP‐CIT‐SPECT

  2008cited by this paper
• Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment

  2008cited by this paper
• Association of olfactory dysfunction with risk for future Parkinson's disease

  2008cited by this paper
• The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?

  2008cited by this paper
• Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility

  2007cited by this paper
• The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation

  2007cited by this paper
• Positron emission tomography in premotor Parkinson's disease.

  2007cited by this paper
• Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease

  2007cited by this paper
• SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.

  2007cited by this paper
• Changes in network activity with the progression of Parkinson's disease.

  2007cited by this paper
• 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients

  2007cited by this paper
• Network modulation in the treatment of Parkinson's disease.

  2006cited by this paper
• Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder

  2006cited by this paper
• Putamen FDOPA uptake and its relationship tot cognitive functioning in PD.

  2006cited by this paper
• Update on the pharmacology of REM sleep behavior disorder

  2006cited by this paper
• Molecular imaging of the dopaminergic system and its association with human cognitive function.

  2006cited by this paper
• Assessing whole brain perfusion changes in patients with REM sleep behavior disorder

  2006cited by this paper
• Cerebral Blood Flow in Parkinson’s Disease, Dementia with Lewy Bodies, and Alzheimer’s Disease according to Three-Dimensional Stereotactic Surface Projection Imaging

  2005cited by this paper
• Slow‐wave sleep and delta power in rapid eye movement sleep behavior disorder

  2005cited by this paper
• Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD)

  2004cited by this paper
• Idiopathic hyposmia as a preclinical sign of Parkinson's disease

  2004cited by this paper
• Serotonergic antidepressants are associated with REM sleep without atonia.

  2004cited by this paper
• Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

  2004cited by this paper
• Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.

  2003cited by this paper
• Increased risk of Parkinson’s disease after depression: A retrospective cohort study

  2002cited by this paper
• Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus.

  2001cited by this paper
• Frequency of bowel movements and the future risk of Parkinson’s disease

  2001cited by this paper
• Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

  2001cited by this paper
• Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

  2000cited by this paper
• Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study

  2000cited by this paper
• Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake

  2000cited by this paper

• Clinical utility and research frontiers of neuroimaging in movement disorders.

  2017cites this paper